VRS
RXRX icon

Virginia Retirement Systems’s Recursion Pharmaceuticals RXRX Stock Holding History

Virginia Retirement Systems’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
+85,700
New +$285K ﹤0.01% 1117
2026
Q1 		– Sell
-29,200
Closed -$119K – 1045
2025
Q4 		$119K Buy
+29,200
New +$145K ﹤0.01% 936

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virginia Retirement Systems's RXRX Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 85,700 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #1117 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in RXRX as recently as Q4 2025.

Virginia Retirement Systems first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Virginia Retirement Systems held 85,700 shares of Recursion Pharmaceuticals worth $315K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Virginia Retirement Systems position in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1117 holding.
  • Virginia Retirement Systems first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.